Previous studies have also shown that scopolamine disrupts the AMPK/SIRT1-SIRT3 signaling pathway, which is closely associated with the Akt/mTOR pathway, further contributing to cognitive deficits (Liu et al., 2024; Abuelezz and Hendawy, 2023). This evidence concerns the gene SIRT3 and Cognitive impairment.